Find psychiatry resources faster

Evidence prioritized, noise reduced

4Psychiatry is a focused search engine for psychiatry. We aggregate clinical guidelines, peer-reviewed research, patient resources, training materials, and vendor listings into a single, specialized index. Our ranking and AI systems prioritize clinical relevance and evidence quality to surface results that matter to psychiatrists, trainees, allied professionals, and informed patients. Use the web, news, shopping, and AI chat features to find answers, keep up with developments, and locate useful products and services. Part of the 4SEARCH network of topic specific search engines.

Latest News & Web Pages

Boise State Public Radio
boisestatepublicradio.org > 2026-03-10 > a-dose-of-psilocybin-helps-smokers-quit-in-new-study

A dose of psilocybin helps smokers quit in new study

3+ hour, 27+ min ago  (818+ words) The long-running campaign against smoking could find reinforcements from the new wave of research into psychedelics. Though much of the attention around psychedelics has focused on depression and other mental health conditions, researchers believe these substances also hold the potential…...

Intelligent Living
intelligentliving.co > lsd-analog-jrt-neuroplasticity

Scientists Engineered LSD Analog, JRT, Targeting Non-Hallucinogenic Neuroplasticity and Brain Repair

20+ hour, 42+ min ago  (1153+ words) The JRT breakthrough does not mean a new drug is ready for pharmacy shelves. JRT remains preclinical. Research evidence suggests that psychiatry may be entering a new design era, one focused less on altered consciousness and more on targeted brain…...

PRLog
prlog.org > 13131878-cchr-cia-mind-control-files-raise-urgent-questions-as-millions-take-psychotropic-drugs.html

CCHR: CIA Mind-Control Files Raise Urgent Questions as Millions Take Psychotropic Drugs

5+ hour, 20+ min ago  (113+ words) CCHR: CIA Mind-Control Files Raise Urgent Questions as Millions Take Psychotropic Drugs'PRLog CCHR: CIA Mind-Control Files Raise Urgent Questions as Millions Take Psychotropic Drugs - December 3, 1951: document stated a person could be reduced "to the vegetable level" through electroshock. - February 12, 1952: memo…...

TradingView
tradingview.com > news > urn:summary_document_transcript:quartr.com:3043918:0-nerv-roluperidone-targets-negative-symptoms-in-schizophrenia-with-a-pivotal-phase-iii-trial-underway

NERV: Roluperidone targets negative symptoms in schizophrenia, with a pivotal phase III trial underway

3+ hour, 52+ min ago  (77+ words) NERV: Roluperidone targets negative symptoms in schizophrenia, with a pivotal phase III trial underway'TradingView Negative symptoms in schizophrenia remain a major unmet need, with roluperidone showing promise in improving both symptoms and daily functioning. The ongoing confirmatory phase III trial,…...

BBC News
bbc.com > news > articles > c4gjy08gmx7o

University of Cumbria to study restrictive eating disorder care

8+ hour, 23+ min ago  (425+ words) The use of restraints and feeding by tubes in NHS eating disorder care is to be studied, with the aim of reducing restrictive practices. The University of Cumbria said the "1.1m project would see it work with researchers, clinicians, young people…...

European Medical Journal
emjreviews.com > cardiology > news > depression-and-visual-impairment-raise-cardiovascular-disease-risk

Depression and Visual Impairment Raise Cardiovascular Disease Risk

4+ hour, 26+ min ago  (313+ words) CARDIOVASCULAR disease (CVD) risk was significantly higher among middle-aged and older Chinese adults with depression, visual impairment (VI), or both, according to new longitudinal cohort data. CVD, which includes conditions such as coronary heart disease and stroke, remains a leading global cause…...

TradingView
tradingview.com > news > urn:summary_document_transcript:quartr.com:3043860:0-nerv-roluperidone-advances-as-a-potential-first-therapy-for-negative-symptoms-in-schizophrenia-backed-by-robust-funding

NERV: Roluperidone advances as a potential first therapy for negative symptoms in schizophrenia, backed by robust funding

4+ hour, 4+ min ago  (73+ words) NERV: Roluperidone advances as a potential first therapy for negative symptoms in schizophrenia, backed by robust funding'TradingView NERV: Roluperidone advances as a potential first therapy for negative symptoms in schizophrenia, backed by robust funding Negative symptoms in schizophrenia remain a…...

Business of Cannabis
businessofcannabis.com > the-cannabis-mental-health-evidence-gap-association-vs-causation

The Cannabis Mental Health Evidence Gap: Association vs. Causation

6+ hour, 7+ min ago  (1103+ words) Home / The Cannabis Mental Health Evidence Gap: Association vs. Causation In our latest Beyond the Abstract, we dive into cannabis use and its impact on mental health, a controversial and understudied field, but one of vital importance for both patient…...

The Straits Times
straitstimes.com > singapore > health > is-your-psychologist-actually-qualified-how-can-you-tell

Is your psychologist qualified? How to check

8+ hour, 27+ min ago  (233+ words) Clearing the air on what different types of psychologists do. ST GRAPHICS: CHEN JUNYI Published'Mar 10, 2026, 06:00 PM Synopsis: Every first Wednesday of the month, The Straits Times helps you make sense of health matters that affect you. The Ministry of Health…...

PsyPost - Psychology News
psypost.org > new-analysis-shows-ideology-not-science-drove-the-global-prohibition-of-psychedelics

New analysis shows ideology, not science, drove the global prohibition of psychedelics

6+ hour, 27+ min ago  (690+ words) A psychotropic substance is simply any chemical that alters how the brain functions, causing changes in mood or awareness. In recent years, medical interest in psychedelics has returned. Early research suggests they could help treat severe mental health conditions. However,…...